Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ISOPAQUE 280

CALCIUM; MEGLUMINE; METRIZOIC ACID

Standard Dose
0.35MG/ML;140.1MG/ML;461.8MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ISOPAQUE 280 is listed in Drugs@FDA under application 017506 (NDA).

Marketing status: Discontinued Active ingredient CALCIUM; MEGLUMINE; METRIZOIC ACID Form and strength INJECTABLE;INJECTION - 0.35MG/ML;140.1MG/ML;461.8MG/ML Sponsor GE HEALTHCARE Submission history Latest submission status date: 2007-12-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview ISOPAQUE 280 is listed in Drugs@FDA under application 017506 (NDA). Marketing status: Discontinued Active ingredient CALCIUM; MEGLUMINE; METRIZOIC ACID Form and strength INJECTABLE;INJECTION - 0.35MG/ML;140.1MG/ML;461.8MG/ML Sponsor GE HEALTHCARE Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.